Artios Pharma has appointed Pierre Legault as Chairman of its Board of Directors, with immediate effect. Pierre, who is based in the US, is a highly accomplished leader in the global biopharmaceutical industry with over 35 years’ experience leading companies through high phases of growth to deliver significant shareholder value. Pierre’s previous roles include chief executive officer of Prosidion, CFO of OSI Pharmaceuticals and he also served as president, CEO and CFO at various legacy companies of the Sanofi-Aventis group. He is currently serving as the chairman of the Board of Poxel, and is a director on the Boards of Syndax Pharmaceuticals, ARMO BioSciences and Clementia Pharmaceuticals.